This study is testing a new drug called DISC-0974 for adults with Chronic Kidney Disease (CKD) and anemia, which means they have fewer red blood cells than normal. The study is in Phase 1b, meaning it's early in testing and focuses on safety and how the body processes the drug. Participants must be 18 or older, not on dialysis, and meet certain health criteria, like having specific blood test results and using reliable birth control if needed.
Key Points:
- Study Duration: The study requires a commitment, but the exact length and number of visits are determined during screening.
- Eligibility: You need to have CKD, be non-dialysis, and meet specific health conditions to participate.
- Considerations: Participants should not have had certain treatments, surgeries, or conditions recently, and must be able to follow study rules.
How understandable was the trial content above?
Hard to understand
Easy to understand